Trials / Sponsors / Forte Biosciences, Inc.
Forte Biosciences, Inc.
Industry · 5 registered clinical trials — 3 currently recruiting.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Recruiting | A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Severe to Very Severe Alopecia Areata. Alopecia Areata | Phase 1 | 2025-10-23 |
| Recruiting | Randomized, Double Blind, Placebo-controlled Phase 2 Study in Adults With Celiac Disease Celiac Disease | Phase 2 | 2025-08-04 |
| Recruiting | A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo Vitiligo | Phase 1 | 2025-03-25 |
| Terminated | Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Mod Atopic Dermatitis | Phase 2 | 2021-06-02 |
| Completed | Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Derm Atopic Dermatitis | Phase 2 | 2020-10-13 |